Dr. Trusheim is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 W 66th St
Ste 150
Edina, MN 55435Phone+1 952-920-7200Fax+1 763-302-4234
Education & Training
- University of MinnesotaResidency, Neurology, 1983 - 1986
- University of Missouri-ColumbiaResidency, Internal Medicine, 1980 - 1983
- University of Missouri-Columbia School of MedicineClass of 1980
Certifications & Licensure
- MN State Medical License 1986 - 2025
- WI State Medical License 1986 - 1993
- IA State Medical License 1987 - 1992
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Sleep Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2011-2012
Clinical Trials
- Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Start of enrollment: 2006 Dec 01
- A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Start of enrollment: 2011 Dec 01
- Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors Start of enrollment: 2014 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 181 citationsAssociation of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A P...Linda M Liau, Keyoumars Ashkan, Steven Brem, Jian L Campian, John E Trusheim
JAMA Oncology. 2023-01-01 - 9 citationsCorrection: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma [J Transl Med., 16, (...Linda M. Liau, Keyoumars Ashkan, David Tran, Jian Campian, John E. Trusheim
Journal of Translational Medicine. 2018-06-29 - 203 citationsFirst results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.Linda M Liau, Keyoumars Ashkan, David D Tran, Jian L Campian, John E Trusheim
Journal of Translational Medicine. 2018-05-29
Press Mentions
- Listening to Patients: Living with Terminal CancerJanuary 16th, 2019
- CNS Oncology Publishes Tumor Treating Fields Treatment Planning and Patient Follow-up Guidelines in GlioblastomaSeptember 19th, 2016
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: